Plains GP (NYSE:PAGP) Upgraded at StockNews.com

Plains GP (NYSE:PAGP - Get Free Report) was upgraded by equities researchers at StockNews.com from a "hold" rating to a "buy" rating in a report issued on Tuesday.

Other research analysts also recently issued reports about the company. Morgan Stanley lifted their target price on Plains GP from $19.00 to $23.00 and gave the stock an "equal weight" rating in a report on Tuesday. Raymond James upped their target price on Plains GP from $23.00 to $24.00 and gave the company a "strong-buy" rating in a report on Tuesday, January 28th. Barclays lifted their target price on shares of Plains GP from $18.00 to $19.00 and gave the stock an "underweight" rating in a research note on Thursday, January 16th. Wolfe Research upgraded Plains GP from a "peer perform" rating to an "outperform" rating and set a $22.00 target price on the stock in a research report on Friday, January 10th. Finally, Wells Fargo & Company downgraded Plains GP from an "overweight" rating to an "equal weight" rating and lowered their target price for the stock from $22.00 to $20.00 in a report on Wednesday, December 18th. Two analysts have rated the stock with a sell rating, three have given a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus price target of $21.00.

Remove Ads

Plains GP Trading Up 0.2 %

PAGP traded up $0.05 during trading on Tuesday, reaching $21.51. 1,416,008 shares of the company's stock were exchanged, compared to its average volume of 1,583,537. The company has a current ratio of 1.01, a quick ratio of 0.92 and a debt-to-equity ratio of 0.49. Plains GP has a one year low of $17.17 and a one year high of $22.31. The firm has a fifty day moving average price of $21.30 and a two-hundred day moving average price of $19.66. The stock has a market capitalization of $4.25 billion, a PE ratio of 40.59 and a beta of 1.55.

Institutional Trading of Plains GP

Hedge funds have recently bought and sold shares of the business. Aegis Wealth Management LLC bought a new position in shares of Plains GP in the fourth quarter valued at $310,000. McIlrath & Eck LLC acquired a new stake in shares of Plains GP in the 4th quarter worth about $166,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in Plains GP by 0.5% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 424,072 shares of the pipeline company's stock valued at $7,794,000 after acquiring an additional 1,997 shares in the last quarter. Vident Advisory LLC acquired a new position in Plains GP during the 4th quarter valued at about $1,751,000. Finally, Two Sigma Advisers LP increased its holdings in Plains GP by 0.5% during the 4th quarter. Two Sigma Advisers LP now owns 4,004,900 shares of the pipeline company's stock worth $73,610,000 after purchasing an additional 19,900 shares in the last quarter. Institutional investors and hedge funds own 88.30% of the company's stock.

About Plains GP

Plains GP Holdings, L.P., through its subsidiary, Plains All American Pipeline, L.P., owns and operates midstream infrastructure systems in the United States and Canada. It operates in two segments, Crude Oil and Natural Gas Liquids (NGLs). The company engages in the gathering and transporting crude oil and NGLs using pipelines, gathering systems, and trucks.